American Association for Cancer Research (AACR) Virtual Annual Meeting Apr 10 - Apr 15, 2021 For details, please view the press release. Supporting Materials Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targeting Mesothelin 3.9 MB Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells Targeting CD70 723.4 KB Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210), a T Cell Receptor Fusion Construct (TRuC®), in Patients with Treatment Refractory Mesothelin Overexpressing Solid Tumors 3.1 MB Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210),… Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells… Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targe… Tools Print Page RSS Feeds Email Alerts Contact IR
Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targeting Mesothelin 3.9 MB Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells Targeting CD70 723.4 KB Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210), a T Cell Receptor Fusion Construct (TRuC®), in Patients with Treatment Refractory Mesothelin Overexpressing Solid Tumors 3.1 MB Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210),… Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells… Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targe…